Prof. Dr. med. Thomas Szucs

Saadany, Tämer El, Seitz, Claudia, Bräm, Corina, & Szucs, Thomas. (2024). Bedside manufacturing as the next step in personalized medicine: medical progress and legal challenges. Journal of Law and the Biosciences, 11(2). https://doi.org/10.1093/jlb/lsae012

Aebersold, Helena, Foster-Witassek, Fabienne, Aeschbacher, Stefanie, Beer, Juerg H., Blozik, Eva, Blum, Manuel, Bonati, Leo, Conte, Giulio, Coslovsky, Michael, De Perna, Maria Luisa, Valentino, Marcello Di, Felder, Stefan, Huber, Carola A., Moschovitis, Giorgio, Mueller, Andreas, Paladini, Rebecca E., Reichlin, Tobias, Rodondi, Nicolas, Stauber, Annina, et al. (2024). Patients on vitamin K treatment: is switching to direct-acting oral anticoagulation cost-effective? A target trial on a prospective cohort. Open Heart, 11(1). https://doi.org/10.1136/openhrt-2023-002567

Hämmerle, Peter, Aeschbacher, Stefanie, Schlageter, Vincent, Coslovsky, Michael, Hennings, Elisa, Krisai, Philipp, Coduri, Federica, Blum, Manuel R., Rodondi, Nicolas, Reichlin, Tobias, Müller, Andreas, Stauber, Annina, Moschovitis, Giorgio, Rigamonti, Elia, Beer, Jürg-Hans, Ammann, Peter, Bonati, Leo H., Conen, David, Osswald, Stefan, et al. (2024). Heart rate variability and stroke or systemic embolism in patients with atrial fibrillation. Heart Rhythm, 21, 1509–1516. https://doi.org/10.1016/j.hrthm.2024.05.028

Mai D, Szucs T. (2024). Gesundheitsversorgung im Strafvollzug Recht und Ethik in der Schweiz. Jusletter.

Mollet, Annette, Laskowski, Nastazja, & Szucs, Thomas. (2024). Postgraduate education and training in drug development sciences: 30 years of the european center of pharmaceutical medicine. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1389349

Schaffner E, Szucs TD. (2024). Gesundheitsversorgung im Strafvollzug Recht und Ethik in der Schweiz. Die Anwendung des Auskunftsrechts, des Rechts auf Berichtigung und des Rechts auf Löschung in Schweizer Spitälern. Life Science Recht.

Foster-Witassek, Fabienne, Aebersold, Helena, Aeschbacher, Stefanie, Ammann, Peter, Beer, Jürg H., Blozik, Eva, Bonati, Leo H., Cattaneo, Mattia, Coslovsky, Michael, Felder, Stefan, Moschovitis, Giorgio, Müller, Andreas, Netzer, Seraina, Paladini, Rebecca E., Reichlin, Tobias, Rodondi, Nicolas, Stauber, Annina, Sticherling, Christian, Szucs, Thomas, et al. (2023). Longitudinal Changes in Health-Related Quality of Life in Patients With Atrial Fibrillation. Journal of the American Heart Association, 12(21). https://doi.org/10.1161/JAHA.123.031872

Aebersold, Helena, Foster-Witassek, Fabienne, Serra-Burriel, Miquel, Brüngger, Beat, Aeschbacher, Stefanie, Beer, Jürg-Hans, Blozik, Eva, Blum, Manuel, Bonati, Leo, Conen, David, Conte, Giulio, Felder, Stefan, Huber, Carola, Kuehne, Michael, Moschovitis, Giorgio, Mueller, Andreas, Paladini, Rebecca E., Reichlin, Tobias, Rodondi, Nicolas, et al. (2023). Estimating the cost impact of atrial fibrillation using a prospective cohort study and population-based controls. BMJ Open, 13(9). https://doi.org/10.1136/bmjopen-2023-072080

Aebersold, Helena, Serra-Burriel, Miquel, Foster-Wittassek, Fabienne, Moschovitis, Giorgio, Aeschbacher, Stefanie, Auricchio, Angelo, Beer, Jürg Hans, Blozik, Eva, Bonati, Leo H, Conen, David, Felder, Stefan, Huber, Carola A, Kuehne, Michael, Mueller, Andreas, Oberle, Jolanda, Paladini, Rebecca E, Reichlin, Tobias, Rodondi, Nicolas, Springer, Anne, et al. (2023). Patient clusters and cost trajectories in the Swiss Atrial Fibrillation cohort. Heart, 109(10), 763–770. https://doi.org/10.1136/heartjnl-2022-321520

Herber, Elena, Aeschbacher, Stefanie, Coslovsky, Michael, Schwendinger, Fabian, Hennings, Elisa, Gasser, Andreas, Di Valentino, Marcello, Rigamonti, Elia, Reichlin, Tobias, Rodondi, Nicolas, Netzer, Seraina, Beer, Jürg-Hans, Stauber, Annina, Müller, Andreas, Ammann, Peter, Sinnecker, Tim, Duering, Marco, Wuerfel, Jens, Conen, David, et al. (2023). Physical activity and brain health in patients with atrial fibrillation. European Journal of Neurology, 30(3), 567–577. https://doi.org/10.1111/ene.15660

Blum, Steffen, Aeschbacher, Stefanie, Aeschbacher, Stefanie, Benkert, Pascal, Meyre, Pascal, Reddiess, Philipp, Ammann, Peter, Erne, Paul, Moschovitis, Giorgio, Di Valentino, Marcello, Shah, Dipen, Schläpfer, Jürg, Müller, Rahel, Beer, Jürg-Hans, Kobza, Richard, Bonati, Leo, Moutzouri, Elisavet, Rodondi, Nicolas, Meyer-Zürn, Christine, et al. (2022). Long-term risk of adverse outcomes according to atrial fibrillation type. Scientific Reports, 12(1). https://doi.org/10.1038/s41598-022-05688-9

Helena, A., Miquel, S.-B., Fabienne, F.-W., Giorgio, M., Stefanie, A., Angelo, A., Beer, J. H., Eva, B., Bonati, L. H., David, C., Stefan, F., Huber, C. A., Michael, K., Andreas, M., Jolanda, O., Paladini, R. E., Tobias, R., Nicolas, R., Anne, S., et al. (2022, June 8). Patient Clusters and Cost Trajectories in Atrial Fibrillation: Evidence from the Swiss Atrial Fibrillation Cohort [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2022.06.07.22275906

Bandiera, Carole, Ribaut, Janette, Dima, Alexandra L., Allemann, Samuel S., Molesworth, Kate, Kalumiya, Kabeza, Käser, Fabian, Olson, Melvin Skip, Burnier, Michel, van Boven, Job F. M., Szucs, Thomas, Albrecht, Daniel, Wilson, Ira, De Geest, Sabina, & Schneider, Marie P. (2022). Swiss Priority Setting on Implementing Medication Adherence Interventions as Part of the European ENABLE COST Action. International Journal of Public Health, 67, 1605204. https://doi.org/10.3389/ijph.2022.1605204

Romanens M, Adams A, Sudano I, Bojara W, Balint S, Warmuth W, & Szucs TD. (2021). Prediction of cardiovascular events with traditional risk equations and total plaque area of carotid atherosclerosis: The Arteris Cardiovascular Outcome (ARCO) cohort study. Preventive Medicine, 147, 106525. https://doi.org/10.1016/j.ypmed.2021.106525

Blum, Steffen, Aeschbacher, Stefanie, Meyre, Pascal, Kühne, Michael, Rodondi, Nicolas, Beer, Jürg-Hans, Ammann, Peter, Moschovitis, Giorgio, Bonati, Leo, Blum, Manuel R., Kastner, Peter, Baguley, Fiona, Sticherling, Christian, Osswald, Stefan, Conen, David, Auberson, Chloé, Bonati, Leo, Ceylan, Selinda, Doerpfeld, Simone, et al. (2021). Insulin-like growth factor-binding protein 7 and risk of congestive heart failure hospitalization in patients with atrial fibrillation. Heart Rhythm, 18(4), 512–519. https://doi.org/10.1016/j.hrthm.2020.11.028

Jeiziner, C., Suter, K., Wernli, U., Barbarino, J. M., Gong, L., Whirl-Carrillo, M., Klein, T. E., Szucs, T. D., Hersberger, K. E., & Meyer Zu Schwabedissen, H. E. (2021). Pharmacogenetic information in Swiss drug labels - a systematic analysis. Pharmacogenomics Journal, 21(4), 423–434. https://doi.org/10.1038/s41397-020-00195-4

13. Drack S, & Szucs TD. (2021). COVID-19-Impfpflicht: Möglichkeiten und Haftung Von Privatrechtlichen Arbeitgebern Von Gesundheitspersonal. Jusletter.

Szucs T. (2021). Die Präzisionsmedizin – massgeschneiderte Medizin statt Massenware. In Hansjakob Müller / Hans-Beat Hadorn (Ed.), Humangenetik und Anthropologie heute. Schwabe.

Horgan D, Metspalu A, Ouillade MC, Athanasiou D, Pasi J, Adjali O, Harrison P, Hermans C, Codacci-Pisanelli G, Koeva J, Szucs T, Cursaru V, Belina I, Bernini C, Zhuang S, McMahon S, Toncheva D, & Thum T. (2020). Propelling Healthcare with Advanced Therapy Medicinal Products: A Policy Discussion. Biomedicine Hub, 5(3), 130–152. https://doi.org/10.1159/000511678

Grossmann, Regina, Schneider, Marcel Andre, Linecker, Michael, Lehn, Jean-Marie, Nicolau, Claude, Traber, Martin, Tay, Fabian, Vicente, Diego, Jetter, Alexander, Mollet, Annette, Szucs, Thomas, Graf, Rolf, Clavien, Pierre-Alain, & Limani, Perparim. (2020). Interprofessional and interdisciplinary collaboration for early phase oncological clinical trials in academia—Myo-inositoltrispyrophophate as model [Journal-article]. Pharmacological Research, 154, 104238. https://doi.org/10.1016/j.phrs.2019.04.022

Leo CP, Leo C, & Szucs TD. (2020). Publisher Correction: Breast cancer drug approvals by the US FDA from 1949 to 2018. (Patent No. 4). 19(4), Article 4. https://doi.org/10.1038/s41573-020-0060-1

Leo CP, Hentschel B, Szucs TD, & Leo C. (2020). FDA and EMA approvals of new breast cancer drugs—a comparative regulatory analysis. Cancers, 12(2). https://doi.org/10.3390/cancers12020437

Szucs, T. (2020). Rechtliche Aspekte von Arzneimitteln mit genomischen Biomarkern im Label (; Editions Weblaw, Trans.). Editions Weblaw.

Thomas D. Szucs, & Corina Bräm. (2020). Gesundheitsforschung mit Versicherungsdaten. Jusletter.

Romanens M, Szucs T, Sudano I, & Adams A. (2019). Agreement of PROCAM and SCORE to assess cardiovascular risk in two different low risk European populations. Preventive Medicine Reports, 13, 113–117. https://doi.org/10.1016/j.pmedr.2018.11.019

Sheikh S, Biundo E, Courcier S, Damm O, Launay O, Maes E, Marcos C, Matthews S, Meijer C, Poscia A, Postma M, Saka O, Szucs T, & Begg N. (2019). Corrigendum to ‘A report on the status of vaccination in Europe’ [Vaccine 36 (2018) 4979-4992]. (Patent No. 10). 37(10), Article 10. https://doi.org/10.1016/j.vaccine.2019.01.038

Blank, Patricia R., Tomonaga, Yuki, Szucs, Thomas D., & Schwenkglenks, Matthias. (2019). Economic burden of symptomatic iron deficiency - a survey among Swiss women. BMC Women’s Health, 19(1), 39. https://doi.org/10.1186/s12905-019-0733-2

Conen, David, Rodondi, Nicolas, Müller, Andreas, Beer, Juerg H., Ammann, Peter, Moschovitis, Giorgio, Auricchio, Angelo, Hayoz, Daniel, Kobza, Richard, Shah, Dipen, Novak, Jan, Schläpfer, Jürg, Di Valentino, Marcello, Aeschbacher, Stefanie, Blum, Steffen, Blum, Steffen, Meyre, Pascal, Sticherling, Christian, Bonati, Leo H., et al. (2019). Relationships of Overt and Silent Brain Lesions With Cognitive Function in Patients With Atrial Fibrillation. Journal of the American College of Cardiology, 73(9), 989–999. https://doi.org/10.1016/j.jacc.2018.12.039

Spirk, David, Sebastian, Tim, Banyai, Martin, Beer, Jürg H., Mazzolai, Lucia, Baldi, Thomas, Aujesky, Drahomir, Hayoz, Daniel, Engelberger, Rolf P., Kaeslin, Thomas, Korte, Wolfgang, Escher, Robert, Husmann, Marc, Mollet, Annette, Szucs, Thomas D., & Kucher, Nils. (2019). Venous Thromboembolism and Renal Impairment: Insights from the SWIss Venous ThromboEmbolism Registry (SWIVTER). Seminars in Thrombosis and Hemostasis, 45, 851–858. https://doi.org/10.1055/s-0039-1698770

Witassek, Fabienne, Springer, Anne, Adam, Luise, Aeschbacher, Stefanie, Beer, Jürg H., Blum, Steffen, Bonati, Leo H., Conen, David, Kobza, Richard, Kühne, Michael, Moschovitis, Giorgio, Osswald, Stefan, Rodondi, Nicolas, Sticherling, Christian, Szucs, Thomas, Schwenkglenks, Matthias, & Swiss-AF study investigators. (2019). Health-related quality of life in patients with atrial fibrillation: The role of symptoms, comorbidities, and the type of atrial fibrillation. PloS One, 14(12), e0226730. https://doi.org/10.1371/journal.pone.0226730

Szucs TD, & El Saadany T. (2019). Learning and Confirming» in Pharmaforschung und -entwicklung. Von Sackgassen und Durchbrüchen. Conexus, 2.

Sheikh S, Biundo E, Courcier S, Damm O, Launay O, Maes E, Marcos C, Matthews S, Meijer C, Poscia A, Postma M, Saka O, Szucs T, & Begg N. (2018). A report on the status of vaccination in Europe. Vaccine, 36(33), 4979–4992. https://doi.org/10.1016/j.vaccine.2018.06.044

Moehrlen, T., Szucs, T., Landolt, M. A., Meuli, M., Schiestl, C., & Moehrlen, U. (2018). Trauma mechanisms and injury patterns in pediatric burn patients. Burns, 44(2), 326–334. https://doi.org/10.1016/j.burns.2017.07.012

Schmidt, Hendrik, Caldwell, Brent, Mollet, Annette, Leimer, Hanns-Georg, & Szucs, Thomas. (2018). An industry experience with data sharing. New England Journal of Medicine, 379(21), 2081–2082. https://doi.org/10.1056/nejmc1805610

Szucs TD, Szillat KP, & Blozik E. (2018). Budget impact model for oncopharmacogenetics from the perspective of mandatory basic health insurance in Switzerland using the example of breast cancer. Pharmacogenomics and Personalized Medicine, 11, 67–69. https://doi.org/10.2147/pgpm.s154368

Jain A.B., Mollet, Annette, & Szucs T.D. (2017). Structural and procedural characteristics of international regulatory authorities. Nature Reviews Drug Discovery, 16(9), 594–595. https://doi.org/10.1038/nrd.2017.135

Wait S., Han D., Muthu V., Oliver K., Chrostowski S., Florindi F., de Lorenzo F., Gandouet B., Spurrier G., Ryll B., Wierinck L., Szucs T., Hess R., Rosvall-Puplett T., Roediger A., Arora J., Yared W., Hanna S., Steinmann K., & Aapro M. (2017). Towards sustainable cancer care: Reducing inefficiencies, improving outcomes—A policy report from the All.Can initiative. Journal of Cancer Policy, 13, 47–64. https://doi.org/10.1016/j.jcpo.2017.05.004

Matter-Walstra KW, Achermann R, Rapold R, Klingbiel D, Bordoni A, Dehler S, Konzelmann I, Mousavi M, Clough-Gorr KM, Szucs T, Schwenkglenks M, & Pestalozzi BC. (2017). Days spent in acute care hospitals at the end of life of cancer patients in four Swiss cantons: a retrospective database study (SAKK 89/09). European journal of cancer care, 26(4). https://doi.org/10.1111/ecc.12453

Szucs TD, Weiss M, & Klaus G. (2017). The enigma of value: in search of affordable and accessible health care. (Patent No. 6). 18(6), Article 6. https://doi.org/10.1007/s10198-016-0857-3

Romanens M, Mortensen MB, Sudano I, Szucs T, & Adams A. (2017). Extensive carotid atherosclerosis and the diagnostic accuracy of coronary risk calculators. Preventive medicine reports, 6, 182–186. https://doi.org/10.1016/j.pmedr.2017.03.006

Blank, P. R., & Szucs, T. D. (2017). Social and economic impact of influenza vaccination Sozialer und ökonomischer Nutzen der Impfung gegen Influenza. Praxis, 106(11), 589–593. https://doi.org/10.1024/1661-8157/a002693

Groux, P., Anchisi, S., & Szucs, T. (2017). Impact of Treatments on the Family of Breast, Prostate, Colon and Lung Cancer Patients [Journal-article]. Cancer and Clinical Oncology, 6(1), 61. https://doi.org/10.5539/cco.v6n1p61

Blank, Patricia R., Ademi, Zanfina, Lu, Xiaoyan, Szucs, Thomas D., & Schwenkglenks, Matthias. (2017). Herpes zoster vaccine: A health economic evaluation for Switzerland. Human Vaccines & Immunotherapeutics, 13(7), 1495–1504. https://doi.org/10.1080/21645515.2017.1308987

Szucs TD. (2017). Medizin und Ökonomie. Therapeutische Umschau. Revue Therapeutique, 73(1), 775. https://doi.org/10.1024/0040-5930/a000863

Risch M, Risch L, Purde MT, Renz H, Ambühl P, Szucs T, & Tomonaga Y. (2016). Association of the cystatin C/creatinine ratio with the renally cleared hormones parathyroid hormone (PTH) and brain natriuretic peptide (BNP) in primary care patients: a cross-sectional study. Scandinavian journal of clinical and laboratory investigation, 76(5), 379–385. https://doi.org/10.1080/00365513.2016.1183262

Groux P., Anchisi S., & Szucs T. (2016). Cancer patient’s contribution to reduce chemotherapy related burden of travel: What would chemotherapy patients agree to do? Open Public Health Journal, 9, 9–15. https://doi.org/10.2174/1874944501609010009

Szucs TD, & Stoffel AW. (2016). Nutrition and health--Why payors should get involved. (Patent No. 5). 32(5), Article 5. https://doi.org/10.1016/j.nut.2015.11.009

Bräm, C., & Szucs, T. (2016). Is it desirable that i must disclose my genetic data to swiss private medical insurances? Public Health Genomics, 19(5), 251–259. https://doi.org/10.1159/000448276

Szucs T., Blozik E., & Reich O. (2016). Between Scylla and Charybdis-the underlying conflict in modern psychiatry between plausibility and affordability Die moderne Psychiatrie im Spannungsfeld zwischen Machbarkeit und Finanzierbarkeit. Swiss Archives of Neurology, Psychiatry and Psychotherapy, 167(6), 177–183. https://doi.org/10.4414/sanp.2016.00419

Szucs TD, Fiorentzis A, & Blank PR. (2016). Wird sich personalisierte Medizin rechnen? Betrachtungen aus gesundheitsökonomischer Sicht. Personalisierte Medizin.

Gutzwiller F.S., Pfeil A.M., Ademi Z., Blank P.R., Braunhofer P.G., Szucs T.D., & Schwenkglenks M. (2015). Cost Effectiveness of Sucroferric Oxyhydroxide Compared with Sevelamer Carbonate in the Treatment of Hyperphosphataemia in Patients Receiving Dialysis, from the Perspective of the National Health Service in Scotland. PharmacoEconomics, 33(12), 1311–1324. https://doi.org/10.1007/s40273-015-0320-9

Vulsteke C, Pfeil AM, Maggen C, Schwenkglenks M, Pettengell R, Szucs TD, Lambrechts D, Dieudonné AS, Hatse S, Neven P, Paridaens R, & Wildiers H. (2015). Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients. Breast Cancer Research and Treatment, 152(1), 67–76. https://doi.org/10.1007/s10549-015-3437-9

Belleli R, Fisch R, & Szucs TD. (2015). Regulatory watch: Efficiency indicators for new drugs approved by the FDA from 2003 to 2013 (Patent No. 3). 14(3), Article 3. https://doi.org/10.1038/nrd4563

Blank P.R., Filipits M., Dubsky P., Gutzwiller F., Lux M.P., Brase J.C., Weber K.E., Rudas M., Greil R., Loibl S., Szucs T.D., Kronenwett R., Schwenkglenks M., & Gnant M. (2015). Cost-Effectiveness Analysis of Prognostic Gene Expression Signature-Based Stratification of Early Breast Cancer Patients. PharmacoEconomics, 33(2), 179–190. https://doi.org/10.1007/s40273-014-0227-x

Pfeil, A M, Imfeld, P, Pettengell, R, Jick, S S, Szucs, T D, Meier, Christoph R, & Schwenkglenks, M. (2015). Trends in incidence and medical resource utilisation in patients with chronic lymphocytic leukaemia : insights from the UK Clinical Practice Research Datalink (CPRD). Annals of Hematology, 94(3), 421–429. https://doi.org/10.1007/s00277-014-2217-7

Szucs T, Quilici S, & Panfilo M. (2015). From population to public institutions: what needs to be changed to benefit from the full value of vaccination. Journal of Market Access & Health Policy, 3. https://doi.org/10.3402/jmahp.v3.26965

Anders M, Trezzi D, Menegazzo R, Aliotta M, Bellini A, Bemmerer D, Broggini C, Caciolli A, Corvisiero P, Costantini H, Davinson T, Elekes Z, Erhard M, Formicola A, Fülöp Z, Gervino G, Guglielmetti A, Gustavino C, Gyürky G, et al. (2014). First direct measurement of the H 2 (α,γ) Li 6 cross section at big bang energies and the primordial lithium problem. Physical Review Letters, 113(4), 42501. https://doi.org/10.1103/PhysRevLett.113.042501

Romanens M, Ackermann F, Sudano I, Szucs T, & Spence JD. (2014). Arterial age as a substitute for chronological age in the AGLA risk function could improve coronary risk prediction [SMW supporting association]. 144, w13967. https://doi.org/10.4414/smw.2014.13967

Matter-Walstra, Klazien, Klingbiel, Dirk, Szucs, Thomas, Pestalozzi, Bernhard C., & Schwenkglenks, Matthias. (2014). Using the EuroQol EQ-5D in Swiss Cancer Patients, Which Value Set Should be Applied? PharmacoEconomics, 32(6), 591–599. https://doi.org/10.1007/s40273-014-0151-0

Pavic, Matea, Pfeil, Alena M, & Szucs, Thomas D. (2014). Estimating the potential annual welfare impact of innovative drugs in use in Switzerland. Frontiers in public health, 2, 48. https://doi.org/10.3389/fpubh.2014.00048

Pfeil, Alena M, Vulsteke, Christof, Paridaens, Robert, Dieudonné, Anne-Sophie, Pettengell, Ruth, Hatse, Sigrid, Neven, Patrick, Lambrechts, Diether, Szucs, Thomas D, Schwenkglenks, Matthias, & Wildiers, Hans. (2014). Multivariable regression analysis of febrile neutropenia occurrence in early breast cancer patients receiving chemotherapy assessing patient-related, chemotherapy-related and genetic risk factors. BMC Cancer, 14, 201. https://doi.org/10.1186/1471-2407-14-201

Snozzi P, Blank PR, & Szucs TD. (2014). Stroke in Switzerland: Social determinants of treatment access and cost of illness. Journal of Stroke and Cerebrovascular Diseases, 23(5), 926–932. https://doi.org/10.1016/j.jstrokecerebrovasdis.2013.07.042

Szucs TD, Puri, Daniele, & Blank, Patricia R. (2014). The use of the EVITA algorithm for clinical assessment of novel agents used in prostate cancer, metastatic melanoma, and systemic lupus erythematosus. European Journal of Clinical Pharmacology, 70(8), 983–990. https://doi.org/10.1007/s00228-014-1698-6

Vulsteke, C, Pfeil, A M, Schwenkglenks, M, Pettengell, R, Szucs, T D, Lambrechts, D, Peeters, M, van Dam, P, Dieudonné, A S, Hatse, S, Neven, P, Paridaens, R, & Wildiers, H. (2014). Impact of genetic variability and treatment-related factors on outcome in early breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide, and docetaxel. Breast Cancer Research and Treatment, 147(3), 557–570. https://doi.org/10.1007/s10549-014-3105-5

Groux P, & Szucs T. (2013). Geographic disparities in access to cancer care: Do patients in outlying areas talk about their access problems to their general practitioners and medical oncologists and how does that impact on the choice of chemotherapy? European Journal of Cancer Care, 22(6), 746–753. https://doi.org/10.1111/ecc.12096

Huber CA, Szucs TD, Rapold R, & Reich O. (2013). Identifying patients with chronic conditions using pharmacy data in Switzerland: An updated mapping approach to the classification of medications. BMC Public Health, 13(1), 1030. https://doi.org/10.1186/1471-2458-13-1030

Tomonaga, Yuki, Risch, Lorenz, Szucs, Thomas D., & Ambuehl, Patrice M. (2013). The Prevalence of Chronic Kidney Disease in a Primary Care Setting: A Swiss Cross-Sectional Study. PLoS ONE, 8(7). https://doi.org/10.1371/journal.pone.0067848

Blank P.R., Schwenkglenks M., Sardos C.S., Patris J., & Szucs T.D. (2013). Population access to new vaccines in European countries. Vaccine, 31(27), 2862–2867. https://doi.org/10.1016/j.vaccine.2013.04.039

Tomonaga Y, Haettenschwiler J, Hatzinger M, Holsboer-Trachsler E, Rufer M, Hepp U, & Szucs TD. (2013). The economic burden of depression in Switzerland. PharmacoEconomics, 31(3), 237–250. https://doi.org/10.1007/s40273-013-0026-9

Gutzwiller, Florian S, Pfeil, Alena M, Comin-Colet, Josep, Ponikowski, Piotr, Filippatos, Gerasimos, Mori, Claudio, Braunhofer, Peter G, Szucs, Thomas D, Schwenkglenks, Matthias, & Anker, Stefan D. (2013). Determinants of quality of life of patients with heart failure and iron deficiency treated with ferric carboxymaltose : FAIR-HF sub-analysis. International Journal of Cardiology, 168(4), 3878–3883. https://doi.org/10.1016/j.ijcard.2013.06.045

Sokolovic E, Riederer F, Szucs T, Agosti R, & Sándor PS. (2013). Self-reported headache among the employees of a Swiss university hospital: prevalence, disability, current treatment, and economic impact. The journal of headache and pain, 14(1), 29. https://doi.org/10.1186/1129-2377-14-29

Szucs, Thomas D, & Pfeil, Alena M. (2013). A systematic review of the cost effectiveness of herpes zoster vaccination. PharmacoEconomics, 31(2), 125–136. https://doi.org/10.1007/s40273-012-0020-7

Rüegg CP, Graf N, Mühleisen B, Szucs TD, French LE, Surber C, & Hofbauer GF. (2012). Squamous cell carcinoma of the skin induces considerable sustained cost of care in organ transplant recipients. Journal of the American Academy of Dermatology, 67(6), 1242–1249. https://doi.org/10.1016/j.jaad.2012.03.033

Blank PR, Bonnelye G, Ducastel A., & Szucs T.D. (2012). Attitudes of the General Public and General Practitioners in Five Countries towards Pandemic and Seasonal Influenza Vaccines during Season 2009/2010. PLoS ONE, 7(10). https://doi.org/10.1371/journal.pone.0045450

Blank PR, & Szucs T.D. (2012). Cost-effectiveness of 13-valent pneumococcal conjugate vaccine in Switzerland. Vaccine, 30(28), 4267–4275. https://doi.org/10.1016/j.vaccine.2012.04.028

Tomonaga Y., Szucs T., Ambuhl P., Nock S., Risch M., & Risch L. (2012). Insights on urinary NGAL obtained in a primary care setting. Clinica Chimica Acta, 413(7-8), 733–739. https://doi.org/10.1016/j.cca.2012.01.001

Schwenkglenks M., Toward T.J., Plent S., Szucs TD, Blackman DJ, & Baumbach A. (2012). Cost-effectiveness of bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitor in the treatment of acute ST-segment elevation myocardial infarction. Heart (British Cardiac Society), 98(7), 544–551. https://doi.org/10.1136/heartjnl-2011-301323

Blank P.R., Schwenkglenks M., & Szucs T.D. (2012). The impact of European vaccination policies on seasonal influenza vaccination coverage rates in the elderly. Human Vaccines and Immunotherapeutics, 8(3), 318–325. https://doi.org/10.4161/hv.8.318629

Blank P, Schwenkglenks M, & Szucs TD. (2012). The impact of European vaccination policies on seasonal influenza vaccination coverage rates in the elderly. Human Vaccines and Immunotherapeutics, 8(3), 318–325. https://doi.org/10.4161/hv.8.318629

Gutzwiller, Florian S., Biller-Andorno, Nikola, Harnacke, Caroline, Bollhalder, Lea, Szucs, Thomas D., Gutzwiller, Felix, & Schwenkglenks, Matthias. (2012, January 1). Methoden zur Bestimmung von Nutzen bzw. Wert medizinischer Leistungen und deren Anwendung in der Schweiz und ausgewählten europäischen Ländern [Akademien der Wissenschaften Schweiz]. http://www.akademien-schweiz.ch/index/Aktuell/News.html

Gutzwiller, Florian S, Schwenkglenks, Matthias, Blank, Patricia R, Braunhofer, Peter G, Mori, Claudio, Szucs, Thomas D, Ponikowski, Piotr, & Anker, Stefan D. (2012). Health economic assessment of ferric carboxymaltose in patients with iron deficiency and chronic heart failure based on the FAIR-HF trial: an analysis for the UK. European Journal of Heart Failure, 14(7), 782–790. https://doi.org/10.1093/eurjhf/hfs083

Kessler R., Keusch G., Szucs T.D., Wittenborn J.S., Hoerger T.J., Brugger U., & Wieser S. (2012). Health economic modelling of the cost-effectiveness of microalbuminuria screening in Switzerland. Swiss Medical Weekly, 142(FEBRUARY). https://doi.org/10.4414/smw.2012.13508

Matter-Walstra, Klazien, Joerger, Markus, Kühnel, Ursula, Szucs, Thomas, Pestalozzi, Bernhard, & Schwenkglenks, Matthias. (2012). Cost-effectiveness of maintenance pemetrexed in patients with advanced nonsquamous-cell lung cancer from the perspective of the swiss health care system. Value in Health, 15(1), 65–71. https://doi.org/10.1016/j.jval.2011.08.1737

Moch, H, Blank, P R, Dietel, M, Elmberger, G, Kerr, K M, Palacios, J, Penault-Llorca, F, Rossi, G, & Szucs, T D. (2012). Personalized cancer medicine and the future of pathology. Virchows Archiv, 460(1), 3–8. https://doi.org/10.1007/s00428-011-1179-6

Pfeil, Alena M, Kressig, Reto W, & Szucs, Thomas D. (2012). Alzheimer’s dementia : budget impact and cost-utility analysis of a combination treatment of a cholinesterase inhibitor and memantine in Switzerland. Swiss Medical Weekly, 142, w13676. https://doi.org/10.4414/smw.2012.13676

Gutzwiller,Florian, Biller-Andorno,Nikola, Harnacke,Caroline, Bollhalder,Lea, Szucs,Thomas D., Gutzwiller,Felix, & Schwenkglenks,Matthias. (2012). Methoden zur Bestimmung von Nutzen bzw. Wert medizinischer Leistungen und ihre ethischen Implikationen. In Akademien der Wissenschaften Schweiz: Vol. -. http://www.zora.uzh.ch/62663/

Farshad M., Gerber C., Szucs T., & Meyer D.C. (2011). Determining utility values in patients with anterior cruciate ligament tears using clinical scoring systems. BMC Health Services Research, 11. https://doi.org/10.1186/1472-6963-11-182

Adlbrecht, C., Huelsmann, M., Berger, R., Moertl, D., Strunk, G., Oesterle, A., Ahmadi, R., Szucs, T., & Pacher, R. (2011). Cost analysis and cost-effectiveness of NT-proBNP-guided heart failure specialist care in addition to home-based nurse care. European Journal of Clinical Investigation, 41(3), 315–322. https://doi.org/10.1111/j.1365-2362.2010.02412.x

Blank, Patricia R, Moch, Holger, Szucs, Thomas D, & Schwenkglenks, Matthias. (2011). KRAS and BRAF mutation analysis in metastatic colorectal cancer : a cost-effectiveness analysis from a Swiss perspective. Clinical Cancer Research, 17(19), 6338–6346. https://doi.org/10.1158/1078-0432.ccr-10-2267

Farshad, Mazda, Gerber, Christian, Meyer, Dominik C, Schwab, Alexander, Blank, Patricia R, & Szucs, Thomas. (2011). Reconstruction versus conservative treatment after rupture of the anterior cruciate ligament : cost effectiveness analysis. BMC Health Services Research, 11, 317. https://doi.org/10.1186/1472-6963-11-317

Joerger, Markus, Matter-Walstra, Klazien, Früh, Martin, Kühnel, Ursula, Szucs, Thomas D., Pestalozzi, Bernhard, & Schwenkglenks, Matthias. (2011). Addition of cetuximab to first-line chemotherapy in patients with advanced non-small-cell lung cancer: a cost-utility analysis. Annals of Oncology, 22(3), 567–574. https://doi.org/10.1093/annonc/mdq431

Kiss, G. G., Rauscher, T., Szuecs, T., Kertesz, Zs, Fueloep, Zs, Gyuerky, Gy, Froehlich, C., Farkas, J., Elekes, Z., & Somorjai, E. (2011). Determining reaction cross sections via characteristic X-ray emission : α-induced reactions on 169Tm for the astrophysical γ-process. Physics Letters. B, 695(5), 419–423. https://doi.org/10.1016/j.physletb.2010.11.052

Schwenkglenks, Matthias, Pettengell, Ruth, Jackisch, Christian, Paridaens, Robert, Constenla, Manuel, Bosly, André, Szucs, Thomas D, & Leonard, Robert. (2011). Risk factors for chemotherapy-induced neutropenia occurrence in breast cancer patients : data from the INC-EU Prospective Observational European Neutropenia Study. Supportive Care in Cancer, 19(4), 483–490. https://doi.org/10.1007/s00520-010-0840-y

Szucs, T. D., Blank, P. R., Schwenkglenks, M., & Aapro, M. (2011). Potential health economic impact of intravenous iron supplementation to erythropoiesis-stimulating agent treatment in patients with cancer- or chemotherapy-induced anemia. Oncology, 81(1), 45–49. https://doi.org/10.1159/000330738

Szucs, Thomas D, Kressig, Reto W, Papageorgiou, Manto, Kempf, Werner, Michel, Jean-Pierre, Fendl, Anton, & Bresse, Xavier. (2011). Economic evaluation of a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in older adults in Switzerland. Human Vaccines, 7(7), 749–756. https://doi.org/10.4161/hv.7.7.15573

Tomonaga, Yuki, Gutzwiller, Felix, Lüscher, Thomas F, Riesen, Walter F, Hug, Markus, Diemand, Albert, Schwenkglenks, Matthias, & Szucs, Thomas D. (2011). Diagnostic accuracy of point-of-care testing for acute coronary syndromes, heart failure and thromboembolic events in primary care : a cluster-randomised controlled trial. BMC Family Practice, 12, 12. https://doi.org/10.1186/1471-2296-12-12

Volz Wenger, A., & Szucs, T. D. (2011). Predictors of family communication of one’s organ donation intention in Switzerland. International Journal of Public Health, 56(2), 217–223. https://doi.org/10.1007/s00038-010-0139-2

Blank, Patricia R, Blank, Armin A, & Szucs, Thomas D. (2010). Cost-effectiveness of oral alitretinoin in patients with severe chronic hand eczema : a long-term analysis from a Swiss perspective. BMC Dermatology, 10, 4. https://doi.org/10.1186/1471-5945-10-4

Blank, Patricia R, Dedes, Konstantin J, & Szucs, Thomas D. (2010). Cost effectiveness of cytotoxic and targeted therapy for metastatic breast cancer : a critical and systematic review. PharmacoEconomics, 28(8), 629–647. https://doi.org/10.2165/11535560-000000000-00000

Blank, Patricia R, Schwenkglenks, Matthias, Moch, Holger, & Szucs, Thomas D. (2010). Human epidermal growth factor receptor 2 expression in early breast cancer patients : a Swiss cost-effectiveness analysis of different predictive assay strategies. Breast Cancer Research and Treatment, 124(2), 497–507. https://doi.org/10.1007/s10549-010-0862-7